In vitro production of β-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase

• Published in: Atherosclerosis 1998-12, Vol.141 (2), p.209-225
• Main Authors: Hong Chung, Byung, Segrest, Jere P, Franklin, Frank
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Carrier Proteins - physiology; Cholesterol - blood; Cholesterol Ester Transfer Proteins; Cholesterol Esters - metabolism; Cholesterylester transfer proteins; Chylomicrons; Disorders of blood lipids. Hyperlipoproteinemia; Fasting - blood; Glycoproteins; High density lipoproteins; Humans; Hypertriglyceridemia - blood; In Vitro Techniques; Intermediate density lipoproteins; Lecithin:cholesterol acyltransferase; Lipolysis; Lipoprotein lipase; Lipoprotein Lipase - physiology; Lipoproteins - blood; Lipoproteins, LDL - blood; Lipoproteins, VLDL - blood; Low density lipoproteins; Medical sciences; Metabolic diseases; Particle Size; Phosphatidylcholine-Sterol O-Acyltransferase - physiology; Postprandial Period; Triglycerides - blood; Very low density lipoproteins
• ISSN: 0021-9150; 1879-1484
• DOI: 10.1016/S0021-9150(98)00169-5

As a model for the formation of β-very low density lipoproteins (VLDL) and small, dense LDL by the intraplasma metabolic activities in vivo, lipoproteins in fresh plasma were interacted in vitro with endogenous lecithin:cholesterol acyltransferase (LCAT) and cholesterylester transfer proteins (CETP) and subsequently with purified lipoprotein lipase (LpL). The LCAT and CETP reactions in a mildly hypertriglyceridemic (HTG) plasma at 37°C for 18 h resulted in (1) esterification of about 45% plasma unesterified cholesterol (UC), (2) a marked increase in cholesterylester (CE) (+129%) and a decrease in triglyceride (TG) (−45%) in VLDL, and (3) a marked increase of TG (+341%) with a small net decrease of CE (−3.6%) in LDL, causing a significant alteration in the TG/CE of VLDL (from 8.0 to 1.9) and of LDL (from 0.20 to 0.93). The LDL in LCAT and CETP-reacted plasma is larger and more buoyant than that in control plasma. In vitro lipolysis of control and LCAT and CETP-reacted plasma by LpL, which hydrolyzed >90% of VLDL-TG and about 50–60% of LDL-TG, converted most of VLDL in control plasma (>85%) but less than half (40%) of VLDL in LCAT and CETP-reacted plasma into the IDL–LDL density fraction and transformed the large, buoyant LDL in the LCAT and CETP-reacted plasma into particles smaller and denser than those in the control plasma. The remnants that accumulated in the VLDL density region of the postlipolysis LCAT and CETP-reacted plasma contained apo B-100 and E but little or no detectable apo Cs and consisted of particles having pre- β and β-electrophoretic mobilities. The inhibition of LCAT during incubation of plasma, which lessened the extent of alteration in VLDL and LDL core lipids, increased the extent of lipolytic removal of VLDL from the VLDL density region but lowered the extent of alteration in the size and density of LDL. The LCAT, CETP and/or LpL-mediated alterations in the density of LDL in normolipidemic fasting plasma were less pronounced than that in mildly HTG plasma, but they became highly pronounced upon increase of its TG-rich lipoprotein level by the addition of preisolated VLDL or by the induction of postprandial lipemia. Although the effect of LCAT, CETP and LpL reactions in non-circulating plasma in vitro may be different from that in vivo, the above data suggests that the plasma TG-rich lipoprotein level and the extent of intraplasma LCAT, CETP, LpL and likely hepatic lipase (HL) reactions in vivo may play a role in determining the LDL